Roopal B. Thakkar
Executive Vice President, Chief Scientific Officer
AbbVie Inc. · ABBV
$9.9M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A filed March 23, 2026. Prior years are from that filing's three-year table.
Catalog as of September 15, 2026. Not a live market feed.
- Salary
- $1.1M
- Stock Awards
- $4M
- Option Awards
- $960K
- Incentives
- $2.4M
- Other
- $1.5M
Compensation History
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,146,154 | $3,980,457 | $9,912,843 |
Current Position
- Company
- AbbVie Inc.
- Title
- Executive Vice President, Chief Scientific Officer
- Ticker
- ABBV · NYSE
- Fiscal Year
- 2025
SEC Sources
Fiscal years below are columns from the latest DEF 14A Summary Compensation Table (filed March 23, 2026), not separate historical filings.
| Fiscal Year | Source |
|---|---|
| 2025 | View SEC filing |
Accession 0001104659-26-033387.
Other AbbVie Executives
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
AbbVie · ABBV
$32.5M
FY 2025 · DEF 14A
Scott T. Reents
Executive Vice President, Chief Financial Officer
AbbVie · ABBV
$12.4M
FY 2025 · DEF 14A
Jeffrey R. Stewart
Executive Vice President, Chief Commercial Officer
AbbVie · ABBV
$15.4M
FY 2025 · DEF 14A
Azita Saleki-Gerhardt
Executive Vice President, Chief Operations Officer
AbbVie · ABBV
$10.8M
FY 2025 · DEF 14A